Fundraising Fox

Epicore Biosystems

Cambridge, US · Founded 2017 · Delaware corporation · 4 known investors

epicorebiosystems.com
Biotech

Founders & leadership

Epicore Biosystems was founded in 2017 by Roozbeh Ghaffari, John Rogers, and Alexander J. Aranyosi.

RGRoozbeh Ghaffari
Roozbeh GhaffariCo-founder
JRJohn Rogers
John RogersCo-founder
AJ
Alexander J. AranyosiCo-founder
SL
Stephen LeeExecutive
JR
James RyanExecutive
JW
John WrightExecutive
JM
Jeffrey ModelExecutive
WL
Weihua LiExecutive

Board

KQ
Kimberly QuerreyBoard director
LL
Laura LangBoard director

Investors · 4

Also in the syndicate · 1

Steele Foundation for Hopelead

Reported raises · per SEC filings

Form D private placements

$37.1M disclosed across 4 rounds · 2018–2024

$25.7MraisedApr 2025 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen LeeExecutive Officer
  • James RyanExecutive Officer
  • Kimberly QuerreyDirector
  • John WrightExecutive Officer
  • Jeffrey ModelExecutive Officer
  • Roozbeh GhaffariExecutive Officer, Director
  • John RogersDirector
  • Alexander J. AranyosiExecutive Officer
  • Weihua LiExecutive Officer
  • Laura LangDirector
Offering amount
$35M
Amount sold
$25.7M
First sale
Dec 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MraisedFeb 2024 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES RYANExecutive Officer
  • JEFF MODELExecutive Officer
  • JOHN ROGERSDirector
  • STEPHEN LEEExecutive Officer
  • JOHN WRIGHTExecutive Officer
  • ROOZBEH GHAFFARIExecutive Officer, Director
  • LAURA LANGDirector
Offering amount
$10M
Amount sold
$1.5M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$9.5MraisedFeb 2022 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROOZBEH GHAFFARIExecutive Officer, Director
  • JOHN ROGERSDirector
Offering amount
$10M
Amount sold
$9.5M
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$350KraisedOct 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John RogersExecutive Officer, Director
  • Roozbeh GhaffariExecutive Officer, Director
Offering amount
$1M
Amount sold
$350K
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Companies competing with Epicore Biosystems for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$299.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$251.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

Who founded Epicore Biosystems?
Epicore Biosystems was founded by Roozbeh Ghaffari, John Rogers, Alexander J. Aranyosi in 2017.
Who are Epicore Biosystems's investors?
Epicore Biosystems's investors include Castor Ventures (an Alumni Ventures Fund), Joyance Partners, Pegasus Tech Ventures.
How much funding has Epicore Biosystems raised?
Epicore Biosystems has disclosed $37.1M raised across 4 rounds.
Where is Epicore Biosystems headquartered?
Epicore Biosystems is headquartered in Cambridge, US.